| Members |
targetComponentId |
| Mixed bacterial vaccine |
Bacteria antigen-containing vaccine product |
| Mixed collagen vascular disease |
Mixed collagen vascular disease (disorder) |
| Mixed collagen vascular disease |
Systemic lupus erythematosus-related syndrome (disorder) |
| Mixed congenital myopathy |
Nemaline myopathy |
| Mixed congenital myopathy |
Eichsfeld type congenital muscular dystrophy |
| Mixed neuronal lesion |
Neuroepithelial tumor morphology of uncertain origin |
| Mixed neuronal lesion |
Neuronal and mixed neuronal-glial tumor |
| Mixed neuronal lesion |
Central nervous system tumour morphology |
| Mixed pinta lesions |
Mixed cutaneous pinta lesion |
| Mixed respiratory vaccine |
Bacteria antigen-containing vaccine product |
| Mixed sedative poisoning NEC |
Poisoning caused by sedative |
| Mizolastine 10mg m/r tablet |
Product containing precisely mizolastine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Mobile joint, function (observable entity) |
Joint mobilisation |
| Mobile joint, function (observable entity) |
Range of joint movement normal |
| Mobility allowance claim: [rep.] or [admin] |
Mobility allowance claim representative (record artifact) |
| Mobility allowance: [exam (& admin)] ) or [MY22 form] |
Mobility allowance medical |
| Mobility allowance: [exam (& admin)] ) or [MY22 form] |
Mobility allowance medical |
| Mobiluncus curtisii |
Mobiluncus curtisii |
| Mobiluncus mulieris |
Mobiluncus mulieris |
| Mobiluncus species |
Mobiluncus |
| Mobiluncus species ribosomal ribonucleic acid |
Ribosomal ribonucleic acid of Mobiluncus (substance) |
| Moccasin - snake |
Agkistrodon bilineatus |
| Moccasin - snake |
Cottonmouth |
| Modafinil 200mg tablet |
Modafinil 200 mg oral tablet |
| Moderate acute malnutrition in infancy childhood and adolescence |
Acute malnutrition in childhood (disorder) |
| Moderate acute malnutrition in infancy childhood and adolescence |
Acute malnutrition in infancy (disorder) |
| Moderate acute malnutrition in infancy childhood and adolescence |
Acute malnutrition in adolescence (disorder) |
| Moderate nutritional stunting in infancy childhood and adolescence |
Nutritional stunting in adolescence (disorder) |
| Moderate nutritional stunting in infancy childhood and adolescence |
Nutritional stunting in childhood (disorder) |
| Moderate nutritional stunting in infancy childhood and adolescence |
Nutritional stunting in infancy (disorder) |
| Moderate nutritional wasting in infancy childhood and adolescence |
Nutritional wasting in adolescence |
| Moderate nutritional wasting in infancy childhood and adolescence |
Nutritional wasting in childhood (disorder) |
| Moderate nutritional wasting in infancy childhood and adolescence |
Nutritional wasting in infancy |
| Moderate to late prematurity of infant |
Moderate preterm infant from 32 weeks up to 33 weeks and 6 days gestation (finding) |
| Moderate to late prematurity of infant |
Preterm infant less than 37 completed weeks gestation (finding) |
| Moderate to late prematurity of infant |
Late preterm infant from 34 weeks up to 36 weeks and 6 days gestation (finding) |
| Moderate underweight in infancy childhood and adolescence |
Underweight in infancy |
| Moderate underweight in infancy childhood and adolescence |
Underweight in adolescence |
| Moderate underweight in infancy childhood and adolescence |
Underweight in childhood |
| Moderately differentiated |
Moderately differentiated (qualifier value) |
| Moderately differentiated |
G2 grade (finding) |
| Moderately differentiated |
Moderately differentiated histological grade finding (finding) |
| Moderately differentiated |
G2 grade (finding) |
| Moderately differentiated |
Moderately differentiated histological grade finding (finding) |
| Moderately differentiated |
G2 grade (finding) |
| Moderately differentiated |
Moderately differentiated histological grade finding (finding) |
| Moderately differentiated |
Moderately differentiated (qualifier value) |
| Moderately differentiated |
Moderately differentiated (qualifier value) |
| Modification - action |
Action |
| Modified radical mastectomy |
Patey total mastectomy (procedure) |
| Modified radical mastectomy |
Patey total mastectomy (procedure) |
| Modified radical mastectomy |
Modified radical mastectomy (procedure) |
| Modified radical mastectomy |
Modified radical mastectomy (procedure) |
| Modified release glyceryl trinitrate allergy |
Allergy to nitroglycerin |
| Modified trace element diet |
Modified mineral diet |
| Modified-release pessary |
Prolonged-release vaginal pessary (dose form) |
| Moellerella species |
Moellerella |
| Molar pregnancy with choriocarcinoma |
Gestational choriocarcinoma (disorder) |
| Molar pregnancy with hydatidiform mole |
Complete hydatidiform mole |
| Molar pregnancy with hydatidiform mole |
Hydatidiform mole, benign (disorder) |
| Molar pregnancy with hydatidiform mole |
Hydatidiform mole, benign (disorder) |
| Molar pregnancy with hydatidiform mole |
Gestational trophoblastic disease (disorder) |
| Molar pregnancy with hydatidiform mole |
Gestational trophoblastic disease (disorder) |
| Molar pregnancy with invasive hydatidiform mole |
Invasive hydatidiform mole (disorder) |
| Molar pregnancy with vesicular mole |
Hydatidiform mole, benign (disorder) |
| Mold technique gamma/beta |
Beta radiation brachytherapy using surface mold applicator (procedure) |
| Mold technique gamma/beta |
Gamma radiation brachytherapy using surface mold applicator (procedure) |
| Mole |
Hydatidiform mole, benign (disorder) |
| Mole |
Family Talpidae (organism) |
| Mole: [fleshy] or [carneous] |
Carneous mole |
| Mollusk, jellyfish, sponge AND/OR echinoderm |
Class Scyphozoa (organism) |
| Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Echinodermata (organism) |
| Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Mollusca (organism) |
| Mollusk, jellyfish, sponge AND/OR echinoderm |
Phylum Porifera (organism) |
| Mometasone furoate 200micrograms breath-actuated dry powder inhaler |
Mometasone furoate 200 microgram/actuation powder for inhalation |
| Mometasone furoate 400micrograms breath-actuated dry powder inhaler |
Mometasone furoate 400 microgram/actuation powder for inhalation |
| Mometasone furoate monohydrate 0.05% aqueous nasal spray |
Mometasone furoate 50 microgram/actuation nasal spray |
| Mometasone furoate monohydrate 0.05% aqueous nasal spray |
Mometasone furoate 50 microgram/actuation nasal spray |
| Mometasone furoate monohydrate 50mcg spray |
Mometasone furoate 50 microgram/actuation nasal spray |
| Mometasone furoate topical preparation |
Product containing mometasone in cutaneous dose form (medicinal product form) |
| Monday, Wednesday and Friday |
Three times a week on Monday, Wednesday and Friday (qualifier value) |
| Mongolian wild ass |
Equus hemionus (organism) |
| Moniezia species |
Moniezia |
| Monitor/alarm/stimulator, device |
Monitor |
| Monitor/alarm/stimulator, device |
Stimulator |
| Monitor/alarm/stimulator, device |
Alarm |
| Monitoring procedure by nursing staff |
Monitoring procedure |
| Monitoring: [obstetric] or [fetal] or [during labour] |
Nonstress test (regime/therapy) |
| Monitoring: [obstetric] or [fetal] or [during labour] |
Obstetric monitoring |
| Monitoring: [obstetric] or [fetal] or [during labour] |
Cardiotochogram (regime/therapy) |
| Monkey hand |
Acquired ape hand |
| Monocillium species |
Genus Niesslia (organism) |
| Monoclonal antibody agent |
Monoclonal antibody |
| Monoclonal paraproteinaemia |
Monoclonal gammopathy (clinical) |
| Monofluoroacetate salt |
Sodium fluoroacetate |
| Mononeuritis lower limb |
Mononeuropathy of lower limb |
| Mononeuritis of lower limb |
Mononeuropathy of lower limb |
| Mononeuritis of upper limb |
Mononeuropathy of upper limb (disorder) |
| Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuropathy of upper limb (disorder) |
| Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuritis multiplex |
| Mononeuritis of upper limb and mononeuritis multiplex |
Mononeuropathy of upper limb (disorder) |